Skip to main content

Peer Review reports

From: PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis

Original Submission
26 Aug 2023 Submitted Original manuscript
28 Sep 2023 Reviewed Reviewer Report
18 Oct 2023 Reviewed Reviewer Report
4 Nov 2023 Reviewed Reviewer Report - Shuguang Zhou
21 Nov 2023 Author responded Author comments - Shuo Wang
30 Nov 2023 Reviewed Reviewer Report
Resubmission - Version 2
21 Nov 2023 Submitted Manuscript version 2
Publishing
4 Dec 2023 Editorially accepted
11 Dec 2023 Article published 10.1186/s12885-023-11715-3

You can find further information about peer review here.

Back to article page